Media 2018-07-10T07:49:54+00:00

IN THE NEWS & PRESS RELEASES

Press Release: July 10, 2018

NuMedii Announces Strategic Research Collaboration with Two Leading Academic Research Institutions Utilizing Single-Cell Sequencing to Identify Precision Therapeutics for IPF

Press Release: June 20, 2018

NuMedii Expands Board of Directors and Scientific Advisory Board with the Addition of Two Oncology Experts

Applied AI – January, 2018

14 Healthcare AI Applications

Pulmonary Fibrosis News – January, 2018

NuMedii Advances IPF Personalized Medicine with New Advisory Board to Guide AI Approach

Medical Device and Diagnostic Industry (MD+DI) – January, 2018

Sifting Nuggets of Truth out of the AI Hooplah

MedCity News – January, 2018

Andy Slavitt: When it comes to AI, it is the best of times, worst of times story

Press Release: January 5, 2018

World’s Leading Lung Disease Experts Join NuMedii’s Idiopathic Pulmonary Fibrosis Advisory Board

WuXi AppTec – October, 2017

Inside Perspectives: NuMedii Banking on Artificial Intelligence to Expedite the Discovery of Effective New Medicines

PharmTech – September, 2017

Expediting the Discovery and Development of Drugs – Drug repurposing, repositioning, and rescue can be faster, cheaper, and target more diseases than traditional drug discovery approaches

Press Release: April 11, 2017

NuMedii, Inc. Announces New Partnership To Discover And Advance New Treatments For Idiopathic Pulmonary Fibrosis

The Scientist – January, 2017

Repurposing Existing Drugs for New Indications

View press release archive…

SOCIAL MEDIA

Follow us on Twitter

4 weeks ago
Congratulations to our #IPF advisor @IPFdoc for the prestigious NIHR Research Professorship! #PrecisionMedicine #bigdata #translationalmedicine in #IPF https://t.co/wO11AZpAJO
1 month ago
Excited to announce our new collaboration in IPF using single cell sequencing with @KaminskiMed @YaleMed and Dr. Ivan Rosas @BrighamWomens! Deepening our discovery efforts with the aim of developing #precisiontherapies https://t.co/vD1CAypeRJ
2 months ago
We have strengthened our BoD with the addition of Dr. Athena Countouriotis and welcome new SAB member Dr. Zemin Zhang. Excited to have these two oncology experts join us! https://t.co/v8bqU8JZjR
5 months ago
Our CEO @biotechfounder highlights our collaboration with @3LakesPartners as "a model going forward for a lot of biotechs". Profiled in the @WSJ: https://t.co/wKZWGRNwcK

Join us on Facebook.

NuMedii
NuMedii7 months ago

Our CEO will be joining other AI experts on Tuesday's lunch panel at #JPM18 is focused on AI. Speakers incl @JamieHeywood @patientslikeme, @ASlavitt, @biotechfounder @NuMedii, @DrShlain @healthloop

NuMedii
NuMedii7 months ago

Warm welcome to our IPF Advisors: Naftali Kaminski, Gisli Jenkins, Toby Maher, David Schwartz, Zea Borok, Paul Wolters and Kevin Brown. Grateful to have your input & help as we develop new therapies for IPF. Thanks Three Lakes Partners for helping us connect!

NuMedii
NuMedii1 year ago

Congratulations @NuMedii co-founder & SAB member @atulbutte, new Chan-Zuckerberg Distinguished Prof! Well deserved!!
https://www.ucsf.edu/news/2017/07/407921/mark-zuckerberg-priscilla-chan-donate-10m-advance-health-using-big-data